Pharma Site Services Limited 11078966 false 2023-10-01 2024-09-30 2024-09-30 The principal activity of the company is Repair Services Digita Accounts Production Advanced 6.30.9574.0 true 11078966 2023-10-01 2024-09-30 11078966 2024-09-30 11078966 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 11078966 1 2024-09-30 11078966 bus:Micro-entities 2023-10-01 2024-09-30 11078966 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 11078966 bus:FilletedAccounts 2023-10-01 2024-09-30 11078966 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 11078966 bus:RegisteredOffice 2023-10-01 2024-09-30 11078966 bus:Director1 2023-10-01 2024-09-30 11078966 bus:Director2 2023-10-01 2024-09-30 11078966 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 11078966 countries:AllCountries 2023-10-01 2024-09-30 11078966 1 2023-10-01 2024-09-30 11078966 1 2023-09-30 11078966 2022-10-01 2023-09-30 11078966 2023-09-30 11078966 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 11078966 1 2023-09-30 11078966 1 2022-10-01 2023-09-30 11078966 1 2022-09-30 iso4217:GBP xbrli:pure

Registration number: 11078966

Pharma Site Services Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 September 2024

image-name
 

Pharma Site Services Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Pharma Site Services Limited

Company Information

Directors

A Thomson

D J O'Malley

Registered office

Lloyds Bank House Lloyds Bank House
Bellingham
Hexham
Northumberland
NE48 2AZ

Accountants

TyneRede Accountancy Ltd
Chartered Certified Accountant
Lloyds Bank House
Bellingham
Hexham
Northumberland
NE48 2AZ

 

Pharma Site Services Limited

(Registration number: 11078966)
Balance Sheet as at 30 September 2024

2024
£

2023
£

Fixed assets

124,757

139,682

Current assets

134,772

104,715

Prepayments and accrued income

804

-

Creditors: Amounts falling due within one year

(63,654)

(42,883)

Net current assets

71,922

61,832

Total assets less current liabilities

196,679

201,514

Accruals and deferred income

(950)

(925)

 

195,729

200,589

Capital and reserves

195,729

200,589

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Lloyds Bank House Lloyds Bank House
Bellingham
Hexham
Northumberland
NE48 2AZ
United Kingdom

These financial statements were authorised for issue by the Board on 4 April 2025.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

3

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £Nil (2023 - £Nil).

 

Pharma Site Services Limited

(Registration number: 11078966)
Balance Sheet as at 30 September 2024

4

Related party transactions

2024

At 1 October 2023
£

Advances to director
£

Repayments by director
£

At 30 September 2024
£

28,487

86,098

(100,000)

14,585

 

2023

At 1 October 2022
£

Repayments by director
£

At 30 September 2023
£

63,919

(35,432)

28,487

 

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 4 April 2025 and signed on its behalf by:
 

.........................................
D J O'Malley
Director